These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12949270)

  • 1. Antinuclear Antibody (ANA) Testing.
    Siegel DM
    Pediatr Rev; 2003 Sep; 24(9):320-1. PubMed ID: 12949270
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antinuclear antibodies in the diagnostics of rheumatic diseases].
    Rose T; Dörner T
    Z Rheumatol; 2020 Jun; 79(5):447-458. PubMed ID: 32458159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of the dense fine speckled pattern and anti-DFS70 antibodies for the diagnosis of systemic autoimmune rheumatic diseases].
    López Sañudo S; Fernández Alonso I; López Hoyos M
    Med Clin (Barc); 2015 Sep; 145(5):218-23. PubMed ID: 26021571
    [No Abstract]   [Full Text] [Related]  

  • 5. Antinuclear antibody testing in a Turkish pediatrics clinic: is it always necessary?
    Aygün E; Kelesoglu FM; Dogdu G; Ersoy A; Basbug D; Akça D; Çam ÖN; Akyüz B; Günsay T; Kapici AH; Aydin NG; Karapinar E; Atay S; Saglam N; Okumus NK; Can MZ; Yazici F; Ömeroglu RE
    Pan Afr Med J; 2019; 32():181. PubMed ID: 31312295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical utility of a positive antinuclear antibody test result.
    Abeles AM; Abeles M
    Am J Med; 2013 Apr; 126(4):342-8. PubMed ID: 23395534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases.
    Bossuyt X; De Langhe E; Borghi MO; Meroni PL
    Nat Rev Rheumatol; 2020 Dec; 16(12):715-726. PubMed ID: 33154583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.
    Solans-Laqué R; Pérez-Bocanegra C; Salud-Salvia A; Fonollosa-Plá V; Rodrigo MJ; Armadans L; Simeón-Aznar CP; Vilardell-Tarres M
    Lupus; 2004; 13(3):159-64. PubMed ID: 15119543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear antibody test: when to order?
    Meroni PL; Chan EK; Tincani A; García de la Torre I; Andrade LE
    Am J Med; 2013 Oct; 126(10):e17. PubMed ID: 24054962
    [No Abstract]   [Full Text] [Related]  

  • 10. The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases.
    Bizzaro N; Brusca I; Previtali G; Alessio MG; Daves M; Platzgummer S; Cinquanta L; Paura G; Infantino M; Manfredi M; Faricelli R; Bassetti D; Musso M; Deleonardi G; Trevisan MT; Radice A; Liguori M; Imbastaro T; Pesente F; Fabris M; Tonutti E
    Autoimmun Rev; 2018 Jun; 17(6):541-547. PubMed ID: 29631063
    [No Abstract]   [Full Text] [Related]  

  • 11. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
    Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
    Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinuclear antibodies: when to test and how to interpret findings.
    Rehman HU
    J Fam Pract; 2015 Jan; 64(1):E5-8. PubMed ID: 25574514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinuclear antibody testing: discordance between commercial laboratories.
    Abeles AM; Gomez-Ramirez M; Abeles M; Honiden S
    Clin Rheumatol; 2016 Jul; 35(7):1713-8. PubMed ID: 27044430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
    Peene I; Meheus L; Veys EM; De Keyser F
    Ann Rheum Dis; 2001 Dec; 60(12):1131-6. PubMed ID: 11709455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reply.
    Abeles AM; Abeles M
    Am J Med; 2013 Oct; 126(10):e19. PubMed ID: 24054963
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
    Tipu HN; Bashir MM
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between antinuclear antibody titers and connective tissue diseases in a Rheumatology Department.
    Menor Almagro R; Rodríguez Gutiérrez JF; Martín-Martínez MA; Rodríguez Valls MJ; Aranda Valera C; de la Iglesia Salgado JL
    Reumatol Clin; 2017; 13(3):150-155. PubMed ID: 27221374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
    Lee H; Kim Y; Han K; Oh EJ
    Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the methods used for the detection of antinuclear antibodies].
    Berkem R; Gümüş T; Karakoç E; Acar N
    Mikrobiyol Bul; 2003; 37(2-3):171-8. PubMed ID: 14593900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated antinuclear immunofluorescence antibody analysis is a reliable approach in routine clinical laboratories.
    Zheng B; Li E; Zhu H; Lu J; Shi X; Zhang J; Li M
    Clin Chem Lab Med; 2017 Oct; 55(12):1922-1930. PubMed ID: 28467309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.